Molecular biology methods for the characterization of Helicobacter pylori infections and their diagnosis (Q36028541)

11 August 2017

1 reference

title

Molecular biology methods for the characterization of Helicobacter pylori infections and their diagnosis (English)

1 reference

11 August 2017

0 references

0 references

Joanne L Simala-Grant

series ordinal

1

1 reference

PubMed ID

15688524

11 August 2017

Diane E Taylor

series ordinal

2

1 reference

11 August 2017

1 November 2004

1 reference

Acta Pathologica et Microbiologica Scandinavica

11 August 2017

1 reference

11 August 2017

112

1 reference

11 August 2017

886-897

1 reference

11 August 2017

11-12

1 reference

Contributions of genome sequencing to understanding the biology of Helicobacter pylori

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Prevalence of Helicobacter pylori resistance to clarithromycin and metronidazole determined by 23S ribosomal RNA and rdxA gene analyses in Hiroshima, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Quantitative detection of Helicobacter pylori gene expression in vivo and relationship to gastric pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pylori genotypes may determine gastric histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Fast and Accurate Quantitative Detection of Helicobacter pylori and Identification of Clarithromycin Resistance Mutations in H . pylori Isolates from Gastric Biopsy Specimens by Real-Time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Molecular typing of Helicobacter pylori by virulence-gene based multiplex PCR and RT-PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Determination of Helicobacter pylori vacA allelic types by single-step multiplex PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Determination of Helicobacter pylori cagA, vacA genotypes with real-time PCR melting curve analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Gastric mucosal density of Helicobacter pylori estimated by real-time PCR compared with results of urea breath test and histological grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

A sequencing method based on real-time pyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Rapid combined characterization of microorganism and host genotypes using a single technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Antimicrobial resistance in Helicobacter pylori isolates from children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pylori resistance to antibiotics: prevalence, mechanism, detection. What's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequences in 30 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Mouse-colonizing Helicobacter pylori SS1 is unusually susceptible to metronidazole due to two complementary reductase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Differentiation of metronidazole-sensitive and -resistant clinical isolates of Helicobacter pylori by immunoblotting with antisera to the RdxA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Genotyping of Helicobacter pylori strains in formalin-fixed or Formaldehyde-sublimate-fixed paraffin-embedded gastric biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

What constitutes failure for Helicobacter pylori eradication therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Development of simplified and rapid detection assay for genetic polymorphisms influencing drug response and its clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

Helicobacter pyloritoxin VacA induces vacuole formation by acting in the cell cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2004.APM11211-1211.X

10.1111/J.1600-0463.2004.APM11211-1211.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15688524